Thursday, 29 September, 2011

Solid Resources – Objective Capital’s Valuation Range - $0.21 - $0.83

Solid Resources
TSXV - SRW
OTCQX - SLDRF

Shares Outstanding - 93.9 million
Fully Diluted - 147.3 million

-----------------------------------------

Objective Capital, a UK based research firm, recently published an Initiation Report on Solid Resources. The 32 page document provides investors with an overview of the company, its properties and builds a case for a $0.21 - $0.83 CDN / share valuation.

That’s represents a value of 2.5 to 9 times the stock’s current sub $0.10 trading price.

Below are some Key Points from of the Report. Please note that the information for the report was accumulated prior to the issuance of all the results of the 2011 drill program.

Solid Resources has a promising early-stage tantalum-tin-rare metals project in an accessible region of northwestern Spain. The company has completed a 2011 drill programme, drilling two mineralised zones, and expects to complete a NI 43-101-compliant resource estimate in October, and achieve quick production thereafter.

• The Doade-Presqueiras property is Solid’s flagship project Solid’s management is focused on exploration and development of its 100 percent owned Doade Presqueiras property in northwestern Spain. The company’s optimism is based on historic tin mining that took place on the property and more recent drilling assays that show encouraging quantities of rare metals, notably tantalum, lithium, niobium and rubidium.

• A significant drilling programme now completed Solid commenced drilling early this year at Doade Presqueiras with the intent of completing 29 holes for 3,500 metres. The drilling was to target a northern zone with 16 infill holes, with 13 holes planned for the southern portion of the
property. This programme was subsequently increased to 31 holes based on an unexpected and highly encouraging assay obtained from the northern zone. Metallurgical work is currently under way and should be complete in November.

• Assays to date have returned significant values of tantalum, tin and rare metals Solid now has assays for 18 holes drilled this year into the northern mineralised zone at Doade Presqueiras, and for 13 holes targeting the southern mineralised zone. Drilling this year suggests the deposit is considerably larger than previously believed. Assays have been significantly higher than in earlier drilling. Local values within the north zone range as high as 207 parts per million (ppm) tantalum, with potential continuity between all areas and with thicknesses of up to 11.5 metres. High-grade mineralisation in the most southern zone, known as Taboazas, has averaged 256 ppm tantalum, 1,216 ppm tin, 0.98% lithium and 167 ppm niobium.

• Tantalum is the emerging story at Doade-Presqueiras Tantalum is a strategic metal, vital for the manufacture of most electronic devices, such as capacitors, cellular telephones, and computers, and without a viable substitute. A substantial proportion of global supply comes from
politically troubled areas and a supply shortfall has sparked a significant price increase recently. Development of a “conflict-free” mine in Spain could ease concerns over the source of supplies – particularly in the consumer electronics industry.

• Solid also has an early stage copper-gold prospect under option in Peru Last year, Solid acquired an option to earn a 100-percent interest in an early stage copper and gold prospect in northwestern Peru. Grab samples have returned anomalous values of gold and copper, ranging as high as 30 grammes of gold per tonne and 1.0 percent copper.

• Solid has recently completed a C$1m financing to further its exploration in Spain and Peru Solid’s management has successfully raised C$1m through a private placement of 10 million shares at C$0.10. Further, the company has a considerable quantity of options and warrants outstanding that could provide several million dollars in a rising market.

• Valuation of Solid yields a base-case valuation of C$0.21 per share Our assessment of Solid Resources and its Doade-Presqueiras project, based on reasonable probabilities of exploration success, yields a base-case valuation of C$0.21. Assuming success at all stages of future exploration and development, our assessment would increase to C$0.39, and with more optimistic assumptions, to C$0.83.

To read the full report, please click here

Tuesday, 20 September, 2011

VentriPoint – Dr. John Kovalchin to Lead Validation of VMS™



VentriPoint Diagnostics Ltd.
VPT - TSX Venture
Shares issued: - 79.4 million
Fully diluted: - 99.6 million

*****************************

Today, VentriPoint announced that Dr. John Kovalchin will lead the clinical trials to validate VMS™ for Tetralogy of Fallot or blue-baby syndrome. John P. Kovalchin, MD, is Director of Echocardiography at The Heart Center at Nationwide Children's Hospital. Associate Professor of Pediatrics at The Ohio State University College of Medicine.

The collaborative trials will include five hospitals - Omaha Children’s in Nebraska; Nationwide in Columbus, Ohio; The Cleveland Clinic and two others.

According to the news release, data from the trial will underpin a submission to the FDA, which is slated for the end of this year.

About Nationwide Children's Hospital

Ranked in the top 12 on U.S. News & World Report's 2007 list of "America's Best Children's Hospitals," Nationwide Children's Hospital is one of the nation's largest pediatric healthcare networks. As home to the Department of Pediatrics of The Ohio State University College of Medicine, Nationwide Children's Hospital physicians train the next generation of pediatricians and pediatric specialists. The Heart Center at Nationwide Children's Hospital is one of five comprehensive centers in the nation dedicated to pediatric cardiac care, education and research. The Heart Center features the latest surgical equipment and diagnostic technology available, including the world's first Hybrid Cardiac Catheterization Suites and the nation's first Congenital Cardiac Hybrid Operating Suite.

Please click here, to view the full news release

Carfinco Lists on S&P/TSX SmallCap Index

Carfinco Income Fund
TSX: CFN.UN
Units outstanding: 24.61 million
Units fully diluted: 24.65 million

------------------------------


On Friday September 16th 2011, Carfinco joined some of the most elite Canadian securities by being placed on the S&P/TSX SmallCap Index.

In order to qualify, Carfinco had to meet a number of key criteria. The index is respected globally and many institutional investors won't look at a company unless it is trading on this index. Companies on this index include such household names as: Air Canada, Canaccord Financial, RONA Inc & many others.

The Fund also announced some changes in management yesterday placing Steve Dykau (formally Vice President of Finance) as the new CFO replacing Troy Graf who has been with Carfinco since its inception in 1996 who now is acting as Chief Operating Officer (COO).

See yesterday's news here...

Monday, 19 September, 2011

Neptune Partnership Opens the Door to Asia


Neptune Technologies & Bioressources

TSXV: NTB - NASDAQ: NEPT
Basic Shares: 48.2 million
Fully diluted: 53.9 million

**************************

Today Neptune Technologies & Bioressources announced that it will be initiating a 50/50 joint venture with Shanghai KaiChuang Deep Sea Fisheries Co. (SKFC) to be able to manufacture and commercialize Neptune’s krill products in Asia. Together the joint venture will be called Neptune-SKFC Biotechnology.

According to the agreement, SKFC will supply all the raw material and Neptune will provide a license to Neptune-SKFC Biotechnology allowing it rights to use its Production Technology IP for the Asian Market in return of a significant upfront payment as well as for royalty payments.

In the release, SKFC CEO Xie Feng states, "This major milestone was part of SKFC's development plan in order to become the world's largest krill fishing company. This partnership should generate production and sales of up to 500MT of krill oil over the next five years."

The Asian market now represents more than 30% of all the Omega 3 market worldwide, China being the largest player in Asia.

To view the full news release, please click here

Friday, 16 September, 2011

BioMedReports: Neptune Has Moved Beyond Downward Catalysts

Neptune Technologies & Bioressources
TSXV: NTB - NASDAQ: NEPT
Basic Shares: 48.2 million
Fully diluted: 53.9 million


**************************


In an article released today by M.E. Garcia, Co-Founder of http://www.biomedreports.com/ and contributer to http://www.seekingalpha.com/, Mr. Garcia outlines the last five weeks of trading for Neptune shareholders.

He cites three main “non-fundamental” reasons for the selling pressure that has existed. Further to that he states, “All three should now be behind them, and that fact alone is likely to be a catalyst for another strong upswing for NEPT.”

The three reasons are as follows:

1) The shares from the $12.5 million financing in April became free-trading on August 18.
2) Some investors may have become worried that Neptune might be subject to the same patent risks as Amarin (AMRN) which was hit very hard starting on August 17th on reports that a key Amarin patent application was rejected by the US Patent and Trademark Office.
3) Just as it seemed NEPT had started rebounding (ie., the stock was up about 7% on good volume on September 1, back to $3.68), another source of non-fundamental pressure hit: the rights offering for Acasti, Neptune's pharmaceutical subsidiary.

Garcia closes out the article with the following statement, “Fundamental developments since April have been nothing but positive, and reinforce our conviction that NEPT can be a stock with a much higher valuation--especially if it gets trial results highlighting Neptune Krill Oil's efficacy in Alzheimer's. Keep in mind that this firm is fast on its feet, and that we should be entering a very strong period of positive news flow.”

To read the full article, please click here

Acasti Oversubscribes Rights Offering

Acasti Pharma
TSXV: APO
Shares Outstanding: 64.4 million
Fully Diluted: 73.6 million


-------------------------------

In the midst of continued market turmoil, Acasti announced today that its Rights Offering which closed on September 14th has been oversubscribed and as a result the company raised over $8 million. As part of the Rights Offering the company issued the maximum number of shares allowable – 6,445,444 shares.

According to management, “The proceeds from the Rights Offering will be used to accelerate the development of CaPre(TM), Acasti's prescription drug candidate directed primarily toward the US clinical development plan. The funds will also be used for the commercialization of Onemia(TM), Acasti's medical food product and for the development of new Over-the-counter (OTC) combination products. Remaining proceeds will be used for business development purposes and increasing working capital."

To view the full news release, please click here

Wednesday, 14 September, 2011

MicroPlanet Secures Six Figure Order from Auzzie Utility

MicroPlanet Technology Corp.
TSXV: MP
OTC Pink: MCTYF
Shares Outstanding: 100.8 million
Fully Diluted: 155.8 million


-------------------------------


Today MicroPlanet announced that it has received a lead order for Low Voltage Regulators (LVR2) from Australian utility, Essential Energy. According to the news release the value of the sale is just over $200,000 and the company is expecting follow-up orders.


MicroPlanet’s LVR2 technology solves common utility problems such as flicker and excessive voltage drop, and dynamically regulates voltage up or down to within 1% of a programmable set point. This precise regulation of voltage ensures grid stability.


The deal marks the second Australian utility to purchase MicroPlanet’s technology. It was facilitated by MicroPlanet’s Australian distributer, SmartGrid Partners.

About Essential Energy


Essential Energy is a NSW Government-owned corporation, with responsibility for building, operating and maintaining Australia’s largest electricity network - delivering essential network services to more than 800,000 homes and businesses across 95 per cent of NSW, parts of southern Queensland and northern Victoria. Click here to visit Essential Energy's website


To view the full news release, please click here

Tuesday, 13 September, 2011

Silvore Fox Updates Investors on 3 Projects



Silvore Fox Minerals (SFX - TSX.V)
Shares Outstanding: 162.4 million
Fully Diluted: 183.3 million
-----------------------------------------------

Today, Silvore Fox updated shareholders on the status of its three projects: Coxheath, Nova Scotia (Copper), Winston Lake (Copper-Zinc) & Madagascar (copper).

Coxheath, Nova Scotia
• Completed a 10-line (approximately 24 km) Titan 24 Deep Earth Imaging survey utilizing both DCIP & MT technologies. Click here to learn about Titan 24 Deep Earth Imaging.
• A further update will be released once a new working plan for Coxheath, likely to include a drilling program, has been developed.

Winston Lake, Ontario
• Geotech Ltd. has completed a 1,061 line kilometer helicopter borne geophysical survey.
• Silvore Fox will announce the survey results and provide further exploration updates on the property after completion of the interpretation process.

Madagascar
• Local partner Gaea Mining has requested additional time from Silvore Fox in order to obtain and provide certain commercial documentation required by Silvore Fox to finalize a formal joint venture agreement on the Madagascar properties. Silvore Fox has agreed to provide GAEA with an extension agreement that will expire on
October 31, 2011.

To read the full release please click here

Monday, 12 September, 2011

Catalyst Provides Clarity on Bayer’s ‘Arctic Wonder’ and Neptune

Neptune Technologies & Bioressources
TSXV: NTB - NASDAQ: NEPT
Basic Shares: 48.2 million
Fully diluted: 53.9 million

**************************
Today Catalyst Equity Research published an update on Neptune Technologies. In the update Robin Cornwell provides shareholders with an explanation as to why Bayer’s ‘Arctic Wonder’ is listed as Temporarily Unavailable on its website.

Reason given: “Bayer Wants to Make ‘Arctic Wonder' Even Better.”

  • Our understanding is clearly that the temporary shutdown has nothing to do with backorder problems or any negative aspects of Neptune Krill Oil “NKO™”.
  • Arctic Wonder has had very positive consumer response – so much so that Bayer & Neptune are in the process of reviewing the composition and the format of the product in order to optimize the potency of NKO™’s exceptional antioxidant content and push the quality standards to higher levels.
  • The objective of the reformulation is to capitalize on the multitude of advantages of NKO™ including extended shelf-life
  • We believe that the supply interruption of Arctic Wonder to the consumer market should be perceived as very positive as it demonstrates the exceptional collaboration between the two companies to produce higher levels of efficacy for NKO™ in a softgel format.
  • Furthermore we continue to expect new products from the Neptune/Bayer relationship over the near future.

In addition, in the report Catalyst maintains its one year share price target of $7.00.

To view the full report, please click here.

Smartcool President Interviewed on Radio Show Today

Smartcool Systems Inc.
TSX.V: SSC
Basic Shares 60.2 million
Fully Diluted 77.4 million

--------------------------------------








George Burnes, president of Smartcool Systems Inc. will be interviewed today on the Organic View radio show by host June Stoyer to discuss the positive environmental impact of innovative technologies which conserve the use of fossil-fuels while reducing overall energy costs.


The interview will take place on September 12, 2011 at 4p.m., Eastern Standard Time and will explore the significant reduction of the carbon footprint and energy consumption produced by the simple installation of a Smartcool electronic module. Smartcool modules are retrofitted to any type of compressor driven air conditioner, cooling system, chiller, or heat pump. Smartcool electronic modules optimize the cycle of a compressor and produce an immediate and quantifiable reduction in energy consumption, and carbon footprints, while generating significant energy cost savings without effecting cooling quality.

“Until we are no longer dependent upon fossil fuels, the energy we never have to use is always the best alternative, said June Stoyer, Executive Producer of the show. “Thanks to innovative technologies like Smartcool, we can reduce our energy consumption, become more energy efficient, with no risk to existing equipment performance and make more of an economic impact as opposed to pursuing alternative energy solutions that are often quite costly and inefficient."


Callers are welcome to join the conversation during the show by calling (917) 932-1068. The live, Internet talk-radio show will stream from the host page at www.blogtalkradio.com/theorganicview.

Thursday, 8 September, 2011

IWG Technologies - Growing A Market It Knows Best

IWG Technologies (TSX-V: IWG)
Basic Shares: 38.1 million
Fully Diluted: 45.6million

--------------------------------------------------------




Business in Vancouver recently published an article on International Technologies growth plans, featuring an interview President and CEO, David Fox.

The article discusses IWG's recent acquisition of an aviation water heater product line from U.S. based Keltech Inc. The water heating technology for aircraft compliments IWG's aviation water treatment systems that it has been selling since 1982.

IWG is looking for further acquisitions focusing in a market subsection it knows best: products and systems that are used in aircraft interiors.

David Fox is quoted as saying that "we're looking throughout the aviation world at products and technologies that are complementary to the things that we're doing."

Carfinco's Good News Continues - Increases Monthly Distribution



Carfinco Income Fund
TSX: CFN.UN
Units outstanding: 24.61 million
Units fully diluted: 24.65 million

--------------------------------------------------------------



Carfinco announced today that the fund will be increasing it's monthly distributions to unitholders by 20% to $0.03 per unit per month from $0.025 starting this month.

Today's increase brings the annual yield to 5.7% based on the $6.30 trading price at the time of this writing.

A second news release from the fund today stated that the Board of Trustees has approved a proposal to convert Carfinco from an income trust to a corporation. The planned conversion will take place January 1st, 2012 subject to shareholder approval.

Post conversion, investors will continue to receive a monthly dividend of $0.03 per share according to management.

Wednesday, 7 September, 2011

Solid’s Final Rare Metals Drill Results Opens Door For New Reserve Report



Solid Resources
TSXV - SRW
OTCQX - SLDRF

Shares Outstanding - 93.9 million
Fully Diluted - 147.3 million

-----------------------------------------


Solid Resources final eight assay results from the 31 hole drill program on the rare metals project in North-western Spain has set the stage for the writing of a 43-101 reserve report, which will turn the spotlight on valuation.

Company CEO Greg Pendura noted in the news release that “The 2011 campaign reported intersects of mineralized pegmatite dykes which were 50-100% greater than the 2003/2005 drill programs.”

Highlights Include:

11 m averaging - 168 ppm Tantalum, 838 ppm Tin and 1.31% Lithium Oxide
10.7 m averaging - 114 ppm Tantalum, 848 ppm Tin and 1.068% Lithium Oxide
2.2 m averaging – 250 ppm Tantalum, 1,320 ppm Tin and 132 ppm Niobium


The final results include two extra holes that were drilled as a result of the high-grade mineralization found in hole SO-11-12 in the northern section of the property. These results confirmed the continuity of the mineralization for an additional 94m into an area that was previously not known to be mineralized.

To view the full news release please click here




Enhanced by Zemanta

Friday, 2 September, 2011

Is it time to be’ Weighted’ in discounted BioTech?

VentriPoint Diagnostics Ltd.
VPT
- TSX Venture
Shares issued: - 79.4 million

Fully diluted: - 99.6 million

*****************************

Today there are many analysts fearing the dollar, many recommending a weighting in gold and/or resources. There is no doubt that the markets are nervous as evidenced by the increasing volatility we are experiencing.

Yet there is one area that continues to attract continual interest. It is in equities where the underlying companies depart from the norm and offer a solution or product which can be a ‘game-changer’.

Emerging companies offer consider potential but have a lot of risk as their offering just might not be bought, or prove to be a lot less than what everyone hoped for.

Yet, the discount on some of these companies is dramatic.

In a recent interview posted on September 1, 2011, Hugh Cleland, the Fund manager of Northern Rivers believes that VentriPoint is trading at a ‘discount’, as one must consider that if the medical community actually buys this product ‘en masse’ its value could be more than 10 times what it trades for today. That is what ‘discount’ means ... the stock value is extremely low and discounted, for when the world responds it will be much higher...and not at a ‘discount’. In fact Hugh states that the potential for VPT could be a lot higher.

We believe that VentriPoint has something the world will actually buy into. VentriPoint offers a product which will improve diagnostics clarity at a considerably lower price than existing technology.

‘Better, faster, smarter’ usually gets a following.

And we are not alone in our thinking, because despite a volatile stock market, the stock is holding extremely well, and more and more trading is showing a lot of ‘buy-in’.

MORE “BUY_IN”

Just last week, (august 27-31, 2011), the world’s largest Cardiologist convention was staged in Paris. The mission of the ESC Congress (European Society of Cardiology) is reducing the burden of cardiovascular disease. This is also the largest medical meeting in Europe, and aims to be the European forum for the latest research in cardiovascular disease, both clinical and experimental.

One of the ways they accomplish this is by showcasing emerging technology in a special showcase pavilion.

VentriPoint was in attendance and had a booth there to showcase their VMS™ system.

Since VentriPoint’s VMS™ system is approved for sale in Europe, we do expect that sales should result. The FDA submission is expected late this year. Amol Karnick, Ventripoints vice president of sales & marketing said - "Doctors who saw the technology immediately understand the benefit of acquiring a 3D volume with standard 2D ultrasound. The ability to achieve MRI equivalent volumes using 2D has significant clinical value."

Of even more interest was the visits by the larger companies which are strong in this space. Strong Interest was given by several key players who had as well as others who are not as well known in this space. Who and how may? At this conference, we are informed that several means more than 6.

The company is on the record as saying that the natural exit and reward for shareholders is attracting a major buyer within the next two years.

Multi-national companies have massive distribution networks and sales and marketing divisions.

The key to VPT is a major seeing the possibility of exploiting the technology within its own large network.

Just imagine what this can mean...the ‘discount ‘we see today in the market can change very quickly.


















Thursday, 1 September, 2011

A Fund Manager’s Attraction To VentriPoint – An Investor & Director

VentriPoint Diagnostics Ltd.
VPT
- TSX Venture
Shares issued: - 79.4 million

Fully diluted: - 99.6 million

*****************************

In late July we notified you of two new key board appointments to VentriPoint. Last week, we featured an interview with Don Black, a successful long time consultant to the U.S. healthcare industry.

This week, we are featuring Hugh Cleland who runs Northern Rivers Funds as part of Blumont Capital Corporation. We spoke with Hugh about why he was attracted to VPT as an investor and director, his perspectives on the company’s technology and what he sees as its potential future valuation.

To listen to the interview, click below.